Is IDXX a good investment in 2026?

IDEXX Laboratories trades at a P/E ratio of 50.5, with high volatility (31.8% annualized). The stock is in a consolidation phase.

What is the risk level of IDXX?

Based on 30-day volatility of 31.8%, IDXX has HIGH risk. Beta of 1.66 indicates higher sensitivity to market movements than average.

IDEXX Laboratories (IDXX) Stock Analysis & Price Target

Q: Does IDXX pay dividends?

IDEXX Laboratories currently does not pay a regular dividend.

Key Metrics

MARKET CAP

$52.86B

P/E RATIO

50.5

BETA

1.66

More volatile

DIV YIELD

N/A

52W HIGH

$769.98

52W LOW

$356.14

VOLATILITY

31.8%

30d annualized

Price Performance

30-DAY PRICE CHART

$694.75 → $660.71-4.90%

30 days agoToday

1-YEAR PERFORMANCE

$437.11 → $660.71+51.2%

IDXX | 52-week chartLast updated: 2/27/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	IDXX	SECTOR AVG	VS SECTOR
P/E Ratio	50.5x	22.0x	↑ 130%
Beta	1.66	0.85	More volatile
30d Volatility	31.8%	22%	Higher risk

TOP HEALTHCARE PEERS

UNH JNJ PFE

Competitors Analysis

Compare IDXX's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
IDXX(You are here)	$660.71	$52.86B	Healthcare	—
UNH	$286.66	$259.67B	Healthcare	VIEW →
JNJ	$243.47	$586.74B	Healthcare	VIEW →
PFE	$27.10	$154.08B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

IDEXX Laboratories is currently trading at $660.71, which is 14.2% below its 52-week high. With a beta of 1.66, the stock shows higher sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDNEUTRAL

VOLUME0.4M(Below avg)

Frequently Asked Questions

Is IDXX a good buy right now?

IDEXX Laboratories trades at 50.5x earnings. This is above market average, reflecting growth expectations. Current risk level is High based on 31.8% volatility.

Does IDXX pay dividends?

IDEXX Laboratories does not currently pay a regular dividend. The company may be reinvesting profits for growth.

How volatile is IDXX?

With 30-day annualized volatility of 31.8% and beta of 1.66,IDXX is classified as High risk. Expect larger swings than the broader market during volatile periods.

Related Assets

LLYANALYZE →

Eli Lilly and Company

Track IDXX Live

Add IDEXX Laboratories to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL

Last updated: 2/27/2026, 2:03:45 PM